Selank and Semax compared to Modafinil: what the science says

What did @coachsugashawn actually say?

The creator stacked Selank and Semax and called the combination "like Adderall and Modafinil having a baby without the side effects." He described the pair as producing "clean dopamine support," better memory, less anxiety, and sharper focus, while repeatedly emphasizing the stack is legal and requires no prescription. He also claimed Semax alone feels "a lot like Adderall."

To be fair, he did acknowledge the drugs' legitimate origins: both peptides were originally developed for neurological injury and PTSD, largely in Soviet-era Russian clinical research. That framing is accurate. But the moment he pivots to "no crashes, no withdrawal, just clean dopamine," the claims get ahead of the evidence considerably. Calling something legal and prescription-free does not mean it is well-studied, standardized, or safe for general use, and that distinction is doing a lot of heavy lifting in this video.

Does the science back this up?

There is genuine research behind both peptides, but almost none of it involves healthy adults using them recreationally for focus. Most of the evidence comes from Russian clinical trials, animal models, and small human studies in patient populations, not the biohacker use case being sold here.

Semax, a synthetic analog of ACTH(4-7), has shown effects on BDNF expression and dopaminergic activity in rodent studies (Dolotov et al., 2006, Journal of Neurochemistry). A small Russian clinical trial found it improved attention in patients recovering from stroke (Gusev et al., 1997). Selank is a synthetic analog of tuftsin with documented anxiolytic effects in animal models and a handful of Russian human trials for generalized anxiety disorder (Semenova et al., 2010, Bulletin of Experimental Biology and Medicine). The combination stack, however, has essentially no controlled human trial data. The "people started stacking them and noticed something wild" origin story is anecdote, not science.

What did they get wrong (or right)?

He got the origin story roughly right. Both compounds were developed in Russian and Soviet research institutions, Semax at the Institute of Molecular Genetics and Selank at the Institute of Molecular Biology, primarily for brain injuries, stroke recovery, and anxiety disorders. Credit where it is due.

What he got wrong is more significant. Saying there are "no side effects" is not supportable. Semax has been associated with irritability, elevated blood pressure, and appetite changes in some users. Selank is better tolerated but data on long-term use is thin. Calling the dopamine effects "clean" implies a pharmacological precision that no published study has demonstrated in healthy adults. And the Modafinil comparison is a stretch: Modafinil acts primarily on orexin and dopamine transporter systems with decades of peer-reviewed human data behind it. Comparing it casually to a nasal peptide stack with a handful of Russian trials is misleading, even if the experiential description sounds similar to some users.

What should you actually know?

Neither Semax nor Selank is FDA-approved. In the United States, they occupy a regulatory gray area: not scheduled as controlled substances, but also not approved for any therapeutic use. They are often sold as "research chemicals" or compounded by peptide pharmacies, and product purity and dosing consistency are real concerns with unregulated sources.

The "no prescription needed" framing is technically true in many cases but misleading in context. It signals safety when it actually signals a lack of regulatory oversight. Telehealth platforms that dispense these compounds are operating under compounding pharmacy rules, which have their own compliance requirements and do not equal FDA approval. If you are considering either peptide, a real medical evaluation, not a TikTok stack guide, is the appropriate starting point. Users with cardiovascular issues, anxiety disorders, or who take SSRIs or MAOIs should be especially cautious given the limited interaction data available.